AltrixBio, Inc. — Form D/A
AltrixBio, Inc. of Lowell, MA, a company, filed a Form D amendment with the SEC on 2025-06-13. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-06-13
- Form: D/A
- Accession: 0001080368-25-000013
- Industry: Pharmaceuticals
- Exemptions: 04, 06c, 4a5
- Total offering: $6.6M
- Amount sold: $6.6M
- Minimum investment: $10K
- Investors: 50
- Date of first sale: 2019-03-08
- Revenue range: Decline to Disclose
- SEC file number: 021-548969
Issuer
- Name: AltrixBio, Inc.
- CIK: 0002040517
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 110 Canal Street, Lowell, MA, 01852
- Phone: 302-658-7581
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Nancy Briefs | Director | London, X0 |
| Nancy Briefs | Executive Officer | London, X0 |
| John Brooks | Director | Mississauga, A6 |
| Jeffrey Karp | Director | Lowell, MA |
| Ali Tavakkoli | Director | Lowell, MA |
Other filings by this issuer (2)
More